Financials in USD. Standardized financial statements.
A compact view of how Jaguar Health, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $11.51M | $11.69M | $9.76M | $11.96M | $4.33M | $9.38M | $5.78M | $4.42M | $4.36M | $141,523 |
| Revenue Growth? | -1.5% | +19.8% | -18.4% | +175.8% | -53.8% | +62.5% | +30.8% | +1.3% | +2981.6% | 0.0% |
| Cost of Revenue? | $3.77M | $1.96M | $2.04M | $2.02M | $2.33M | $3.28M | $3.82M | $2.77M | $880,405 | $51,966 |
| Gross Profit? | $7.74M | $9.73M | $7.72M | $9.94M | $2.00M | $6.11M | $1.96M | $1.65M | $3.48M | $89,557 |
| Gross Margin? | +67.2% | +83.3% | +79.1% | +83.1% | +46.2% | +65.1% | +33.9% | +37.4% | +79.8% | +63.3% |
| Operating Expenses? | $53.65M | $40.56M | $42.02M | $44.35M | $42.71M | $32.75M | $30.91M | $27.26M | $18.60M | $13.68M |
| Operating Income? | -$45.91M | -$30.83M | -$34.29M | -$34.41M | -$40.71M | -$26.65M | -$28.95M | -$30.82M | -$34.25M | -$13.59M |
| EBITDA? | -$45.91M | -$36.66M | -$32.76M | -$33.38M | -$42.37M | -$28.74M | -$30.87M | -$27.77M | -$11.13M | -$13.70M |
| Income Before Tax | -$54.00M | -$39.25M | -$41.90M | -$48.40M | -$52.60M | -$33.81M | -$38.53M | -$32.15M | -$35.15M | -$14.73M |
| Income Tax Expense | -$422,000 | $0 | $0 | $0 | $0 | $0 | $10,000 | $0 | -$13.18M | $0 |
| Net Income? | -$53.58M | -$38.49M | -$41.30M | -$47.45M | -$52.59M | -$33.81M | -$38.54M | -$32.15M | -$21.97M | -$14.73M |
| EPS? | $-803.95 | $-4574.07 | $-93992.00 | $-1899528.00 | $-4631759.00 | $-11814153.00 | $-106403456.00 | $-1810550318.00 | $-6325593752.00 | $-16744218756.00 |
| Diluted EPS? | $-803.95 | $-4574.07 | $-93992.00 | $-1899528.00 | $-4631759.00 | $-11814153.00 | $-106403456.00 | $-1810550318.00 | $-6325593752.00 | $-16744218756.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality